Evaluation of an Investigational Wearable Vital Signs Monitoring Device in Healthy Infants
Status
Conditions
Treatments
Details and patient eligibility
About
The primary objective of this study is to evaluate the feasibility of the use of an investigational wearable vital sign monitoring device in infants.
Full description
Vital sign monitoring of infants outside of a traditional healthcare setting has already been shown to significantly decrease mortality for children with single ventricle congenital heart disease (1V CHD), a fragile group of patients with congenital heart disease (CHD). Therefore, there is a critical need to develop an accurate, at-home vital sign monitoring system for infants to expand the benefits of remote monitoring to further patient populations. The investigators believe that allowing for continuous monitoring at a clinical standard with interpretations and alerts built into the technology will result in an even greater decline in mortality for infants with 1V CHD, improved clinical outcomes for all infants with CHD, and increased well-being for healthy infants.
To achieve this goal, the investigators are developing a health monitoring system that collects numerical data and physiological waveforms describing heart rate (HR), respiratory rate (RR), pulse oximetry (SpO2), regional oxygen saturation, temperature, and infant motion.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Patient admitted to either the newborn nursery, pediatric cardiac intensive care unit (PCICU), or pediatric care unit (PCU)
- Parent provided written informed consent
Exclusion criteria
- Foster or ward of the state
Trial design
Primary purpose
Allocation
Interventional model
Masking
3 participants in 1 patient group
Trial contacts and locations
Loading...
Central trial contact
Kate Calligy, BSN
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal